Hospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2021

  1. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study

    RMD Open, Vol. 7, Núm. 3

2018

  1. Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: Results from BIOBADASER

    Arthritis Research and Therapy, Vol. 20, Núm. 1

  2. Status of Rheumatology in Spain in 2017: 2.0 Rheumatologists per 100,000 Population

    Reumatologia Clinica

2017

  1. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 196-202

2015

  1. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

2011

  1. No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis

    Clinical and Experimental Rheumatology

2010

  1. Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression

    Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68

1999

  1. Prevention of αIIbβ3 activation by non-steroidal antiinflammatory drugs

    FEBS Letters, Vol. 446, Núm. 2-3, pp. 318-322